Hsa_circ_0111738 Inhibits Tumor Progression and Angiogenesis in Multiple Myeloma by Sponging miR-1233-3p to Regulate HIF-1 Signaling Pathway.

[1]  Zhe Li,et al.  Translation role of circRNAs in cancers , 2021, Journal of clinical laboratory analysis.

[2]  J. Qian,et al.  Review on circular RNAs and new insights into their roles in cancer , 2021, Computational and structural biotechnology journal.

[3]  Y. Wang,et al.  HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway. , 2020, Journal of biological regulators and homeostatic agents.

[4]  Yong Chen,et al.  CircRNA ITCH increases bortezomib sensitivity through regulating the miR-615-3p/PRKCD axis in multiple myeloma. , 2020, Life sciences.

[5]  M. Kot,et al.  Influence of metformin on HIF-1 pathway in multiple myeloma , 2020, Pharmacological Reports.

[6]  Beicheng Sun,et al.  lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway , 2020, Cancer management and research.

[7]  M. Gorospe,et al.  Circular RNAs in Blood Malignancies , 2020, Frontiers in Molecular Biosciences.

[8]  Feng Yan,et al.  Circular RNA hsa-circ-0007766 modulates the progression of Gastric Carcinoma via miR-1233-3p/GDF15 axis , 2020, International journal of medical sciences.

[9]  Dan Sun,et al.  Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. , 2020, Trends in cancer.

[10]  G. Ren,et al.  CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis. , 2020, Biochemical and biophysical research communications.

[11]  X. Liu,et al.  hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma , 2020, Cancer management and research.

[12]  Wei Wei,et al.  Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma , 2020, BMC Cancer.

[13]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[14]  S. Rajkumar.  Multiple myeloma: Every year a new standard? , 2019, Hematological oncology.

[15]  G. Pan,et al.  CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway , 2019, Journal of Experimental & Clinical Cancer Research.

[16]  D. Hermann,et al.  Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFα and angiogenic VEGF , 2019, Aging.

[17]  T. Takeda,et al.  Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB , 2018, Laboratory Investigation.

[18]  Junjie Xiao,et al.  Circular RNAs: Promising Biomarkers for Human Diseases , 2018, EBioMedicine.

[19]  Y. Padwad,et al.  HIF-1 in cancer therapy: two decade long story of a transcription factor , 2017, Acta oncologica.

[20]  D. Kazandjian.  Multiple myeloma epidemiology and survival: A unique malignancy. , 2016, Seminars in oncology.

[21]  E. Borsi,et al.  Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma. , 2015, Translational research : the journal of laboratory and clinical medicine.

[22]  S. Rajkumar.  Updated Diagnostic Criteria and Staging System for Multiple Myeloma. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.